Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor/liver X receptor pathway
This study investigated the effects and mechanisms of TAM-induced steatosis in the liver. The effects and mechanisms of TAM on hepatocyte lipid metabolism were assessed using C57BL/6 female mice and human hepatoma cells. TAM promoted fat accumulation in the liver by upregulation of Srebp-1c expression. Regarding the molecular mechanism, TAM promoted the recruitment of the auxiliary transcriptional activator, p300, and dissociated the auxiliary transcriptional repressor, nuclear receptor corepressor (NCOR), of the complexes, which led to enhancement of Srebp-1c transcription and an increase of triglyceride (TG) synthesis. Vitamin D (VD), a common fat-soluble vitamin, can decrease TAM-induced NAFLD by promoting p300 dissociation and NCOR recruitment. Tamoxifen promoted the recruitment and dissociation of co-transcription factors on the LXR/ER/RXR receptor complex, leading to a disorder of liver lipid metabolism. VD interfered with TAM-induced liver lipid metabolism disorders by reversing this process.PMID:38191086 | DOI:10.1016/j.cbi.2024.110865
Source: Chemico-Biological Interactions - Category: Molecular Biology Authors: Maoxuan Wu Jie Wang Wanqing Zhou Mengting Wang Chunyan Hu Ming Zhou Kailin Jiao Zhong Li Source Type: research
More News: Alcoholism | Breast Cancer | Cancer | Cancer & Oncology | Chemistry | Fatty Liver Disease (FLD) | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Men | Molecular Biology | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Tamoxifen | Urology & Nephrology | Vitamin D | Vitamins